National Institute for Health and Clinical Excellence (NICE – UK)

  • Asthma
  • Breast cancer
  • Chemotherapy-induced anaemia
  • Diabetes (type 2)
  • Hepatitis B
  • Multiple myeloma
  • Multiple sclerosis (MS)
  • Psoriasis
  • Rheumatoid arthritis
  • Secondary hyperparathyroidism in end stage renal disease